PCSK9: a key modulator of cardiovascular health.


Since the discovery of proprotein convertase subtilisin kexin 9 (PCSK9) in 2003, this PC has attracted a lot of attention from the scientific community and pharmaceutical companies. Secreted into the plasma by the liver, the proteinase K-like serine protease PCSK9 binds the low-density lipoprotein (LDL) receptor at the surface of hepatocytes, thereby… (More)
DOI: 10.1161/CIRCRESAHA.114.301621


3 Figures and Tables